{
  "oags": "0.2",
  "status": "alpha",
  "entry": {
    "id": "IB-arxiv-2605.04265-drugformdta-r-07",
    "type": "evidence",
    "claim": "Fine-tuning DrugFormDTA on a curated set of 43,005 viral protein-ligand binding measurements boosted binding-affinity correlation from r = 0.5 to r = 0.7.",
    "evidence_grade": "E3",
    "state": "active",
    "primary_source_ref": [
      {
        "kind": "arxiv",
        "id": "2605.04265",
        "version": "v1",
        "url": "https://arxiv.org/abs/2605.04265",
        "locator": "abstract"
      }
    ],
    "quantities": {
      "n_binding_measurements": 43005,
      "r_before": 0.5,
      "r_after": 0.7
    },
    "declared_loss": null,
    "source_title": "Benchmarking open-source tools for in silico antiviral drug discovery",
    "authors": [
      "Daniel C. Elton",
      "Preston W. Estep"
    ],
    "result_origin": "measured",
    "support_quote": "Fine-tuning DrugFormDTA on our custom cleaned antiviral dataset boosted performance from $r=0.5$ to $r=0.7$",
    "source_version": "v1",
    "abstract_check": {
      "version": "v1",
      "date": "2026-10-08",
      "quote_verbatim": true
    },
    "domain_v2": "q-bio/drug-discovery"
  },
  "expand": [],
  "incoming": [],
  "links": [],
  "declared_losses": [
    "Public evidence-graph projection: internal analytic/theory edges and private provenance are withheld by design.",
    "Alpha: some primary-source refs await precise citation verification."
  ],
  "generated": "2026-10-08"
}